PT-141 is a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound acts by stimulating specific receptors across the body, resulting to augmented sexual function. Preclinical studies have revealed that PT-141 has the potential to remarkably manage a spectrum of sexual dysfun